R Preston Mason

11PUBLICATIONS
22CO-AUTHORS
Life cycle assessment and industrial ecologyEpidemiological methodsNutritional epidemiologyFood properties (incl. characteristics and health benefits)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 25, 2025
Eicosapentaenoic acid limits the more rapid oxidation of lipoprotein(a) compared with other apolipoprotein B particles.

Samuel C R Sherratt, Peter Libby, Richard L Dunbar

|Feb 19, 2025
Cardiovascular Outcomes With Icosapent Ethyl by Baseline Low-Density Lipoprotein Cholesterol: A Secondary Analysis of the REDUCE-IT Randomized Trial.

Rahul Aggarwal, Deepak L Bhatt, Ph Gabriel Steg

|Jul 03, 2024
Eicosapentaenoic Acid Improves Endothelial Nitric Oxide Bioavailability Via Changes in Protein Expression During Inflammation.

Samuel C R Sherratt, Peter Libby, Hazem Dawoud

|Jan 22, 2024
Do patients benefit from omega-3 fatty acids?

Samuel C R Sherratt, R Preston Mason, Peter Libby

|Dec 29, 2022
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues.

Samuel C R Sherratt, Peter Libby, Matthew J Budoff

|Aug 11, 2022
Potential effects of icosapent ethyl on cardiovascular outcomes in cigarette smokers: REDUCE-IT smoking.

Michael Miller, Deepak L Bhatt, Ph Gabriel Steg

Pageof 2